Molecular Cancer Therapeutics

Molecular Cancer Therapeutics

Frequency: Monthly
ISSN: 1535-7163
e-ISSN: 1538-8514

Molecular Cancer Therapeutics publishes translational research studies focused on the discovery and preclinical development of therapeutic agents for oncology. To reflect the evolving field of therapeutics, the journal’s interest extends to all selective drugs including small molecule inhibitors, antibody-drug conjugates, antibody cytokine fusions, bispecific antibodies, cell therapies, gene therapies, radio-immunotherapeutics, vaccines, viral therapies, and other experimental approaches in oncology.

Specific areas of interest are the disclosure of translational investigations of novel drug therapies, preclinical studies of approved therapeutics (including their combination with radiation therapy), mechanisms of action, mitigation of resistance, biomarkers of response, novel models and technology, and applications of big data in drug discovery.

Title information

Molecular Cancer Therapeutics welcomes submission of original research and review articles to the journal. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.

The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Information for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal. Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly significant research are accepted for publication.

Editorial oversight of Molecular Cancer Therapeutics and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board with support from journal staff. See Editorial Board for more information.

For detailed metrics about Molecular Cancer Therapeutics and the other AACR journals, see AACR Journals Metrics.

Submit your article to Molecular Cancer TherapeuticsSmartSubmit.

Publisher: American Association for Cancer Research
No votes yet